Emmes releases standalone cloud software product, Advantage eClinical

By The Science Advisory Board staff writers

May 13, 2022 -- Emmes will unveil the third generation of its Advantage eClinical software at the Society for Clinical Trials annual meeting in San Diego. This newly updated program functions as a standalone cloud software product, with improved utility and insights for clinical trial sponsors.

The platform comes equipped with apps related to study design, electronic data capture, randomization and trial supply management, patient-reported outcomes, safety data and reporting, risk monitoring, source data verification, and specimen tracking. The platform will be available for purchase alongside data consultation services or as a standalone product.

This new version of Advantage eClinical enables higher quality data and facilitates the oversight of clinical trials in a timely manner, reducing costs as well. Furthermore, the new platform promotes rapid study builds with greater flexibility for a variety of clinical trial sponsor companies.

Copyright © 2022 scienceboard.net
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here